Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Novartis arthritis drug fails to prove it is significantly better than rival
Novartis said Cosentyx, when used to treat active psoriatic arthritis, "narrowly missed statistical significance for superiority"…
After sartans and ranitidine, where will NDMA show up next?
While regulators and pharma companies try to understand if it is the product or the process that is at fault in the ranitidine…
Express Pharma November 01-15, 2019
India's Foremost Pharma & Biotech Magazine ~ Next-Gen Workforce For A Digital Era
FDA approves Biogen and Alkermes’ multiple sclerosis drug
The approval is good news for Biogen as its top-selling drug Tecfidera, also a multiple sclerosis treatment, is facing patent…
India to scale-up triple-drug therapy to eliminate elephantiasis
The parasitic infection, known as lymphatic filariasis, is spread by mosquitoes and contracted in childhood, often before the age…
MSF and TB activists protest at 50th Union World Conference on Lung Health
The protesters urged pharma corporations to make improved drug-resistant TB (DR-TB) treatment affordable and available for…
Novartis’ Zolgensma study halted by FDA amid safety questions
The US Food and Drug Administration's partial hold on the so-called STRONG trial impacts patients aged up to five with spinal…
Indoco’ Q2FY20 revenues grow at 21 per cent
For the quarter, the Company posted a profit of 7.3 crores, as against loss of 7.8 crores, same quarter last year
Germany now Europe’s leading pharma industry – CPhI Worldwide ranking
The findings were published in a report which provides vital insights into the world’s leading pharma economies across all…
GSK announces tuberculosis vaccine Phase IIb Trial results
The Indian government has made the fight against TB a central priority and boldly pledged to end TB by 2025, five years before the…